Search

Your search keyword '"Delrieu, Julien"' showing total 331 results

Search Constraints

Start Over You searched for: Author "Delrieu, Julien" Remove constraint Author: "Delrieu, Julien"
331 results on '"Delrieu, Julien"'

Search Results

2. Developing Digital Twins to Assist in the Control of Nuclear Complex Processes

3. Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer’s disease neuroimaging initiative: cross-sectional and longitudinal retrospective analyses

5. Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort

8. Plasma p-tau181 as an outcome and predictor of multidomain intervention effects: a secondary analysis of a randomised, controlled, dementia prevention trial

11. Benzodiazepine use and neuroimaging markers of Alzheimer’s disease in nondemented older individuals: an MRI and 18F Florbetapir PET study in the MEMENTO cohort

13. Meal-related difficulties and weight loss in older people: Longitudinal data from MAPT study

15. Relationship of regional brain &bgr;-amyloid to gait speed

18. Adherence to multidomain interventions for dementia prevention: Data from the FINGER and MAPT trials

19. Plasma p-tau181 as an outcome and predictor of multidomain intervention effects: a secondary analysis of a randomised, controlled, dementia prevention trial

22. Mild behavioral impairment domains are longitudinally associated with pTAU and metabolic biomarkers in dementia‐free older adults.

23. A blood-based nutritional risk index explains cognitive enhancement and decline in the multidomain Alzheimer prevention trial

24. AMYPAD: Correlation of Amyloid PET results with anxiety and depressive symptoms in SCD+, MCI and dementia patients

25. Red blood cell membrane omega-3 fatty acid levels and physical performance: Cross-sectional data from the MAPT study

26. Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study

28. Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort

30. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial

32. Integrative Multimodal Metabolomics to Early Predict Cognitive Decline Among Amyloid Positive Community-Dwelling Older Adults.

33. Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease.

38. Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline

39. Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial

40. Low circulating adropin concentrations predict increased risk of cognitive decline in community-dwelling older adults.

43. Steps towards the implementation of amyloid‐PET in memory clinics: AMYPAD Diagnostic and Patient Management Study

44. Association between physical activity, growth differentiation factor 15 and bodyweight in older adults: A longitudinal mediation analysis

45. Geometric morphometric study of aging mandible

46. Immunothérapie passive dans la maladie d'Alzheimer : état des lieux et applicabilité en population gériatrique.

47. Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study

49. Additional file 3 of Plasma MCP-1 and changes on cognitive function in community-dwelling older adults

50. Additional file 7 of Plasma MCP-1 and changes on cognitive function in community-dwelling older adults

Catalog

Books, media, physical & digital resources